Drugs / HIV-specific CD8 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02563509 | Jan 2016 → Jun 2017 | HIV infectious disease | Guangzhou 8th People's Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV-specific CD8 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02563509 ↗ |
| Modality | Cell therapy | “by transfusing the clone cells modified by specific HIV antigen” NCT02563509 ↗ |
| Route | Other | “Transfusing HIV-specific CD8 cells 50-100mlonce a week for four times.” NCT02563509 ↗ |